Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III, randomized, open-label, controlled trial.

Diabetes Obes Metab · 2021 · PMC8361736 · PMID 33783964

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep > .1so close (0.05 < p ≤ 0.1)

2.8%); however, this difference did not reach statistical significance ( p > .1) and all events were mild in severity, with none leading to treatment discontinuation.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.